|Articles|March 1, 2001
- Pharmaceutical Executive-03-01-2001
The Reality of Virtual Reality
Of course, Digital Pharma and the drug Virtua are fantasy. But the digital technologies highlighted in the fictional news story are available today.
Advertisement
Articles in this issue
almost 25 years ago
See No Evilalmost 25 years ago
Language, Layout, & Links: Creating Trustworthy Online MessagesNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
2
Pharmaceutical Executive Daily: FDA Names Tracy Beth Høeg as Acting Director of CDER
3
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
4
FDA Approves Breyanzi for Adults with Relapsed or Refractory Marginal Zone Lymphoma
5
